Rheumatoid arthritis complicating adjuvant interferon-alpha therapy for malignant melanoma.
Johnson
D M
DM
Hayat
S Q
SQ
Burton
G V
GV
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000139:chemically induced* / Q000188:drug therapy; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008545:Melanoma / Q000150:complications / Q000628:therapy*; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000150:complications / Q000628:therapy*
D000970:Antineoplastic Agents; D018501:Antirheumatic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins